Invention Grant
US06221396B1 Oral cisapride dosage forms with an extended duration 失效
口服西沙必利剂型延长持续时间

Oral cisapride dosage forms with an extended duration
Abstract:
The present invention provides sustained release oral solid dosage forms of cisapride by using a multi-particulate system, which are bioavailable and can provide efficient blood level of cisapride over 24 hours. Unit dosage forms of cisapride which comprise a plurality of substrates containing sustained release cisapride, as well as pharmaceutical compositions containing the dosage forms, are also disclosed herein.
Information query
Patent Agency Ranking
0/0